Urokinase

urokinase-type plasminogen activator (uPA)

The role of soluble urokinase plasminogen activator receptor (suPAR) in the diagnostics of diabetic foot infection.

The role of soluble urokinase plasminogen activator receptor (suPAR) in the diagnostics of diabetic foot infection.

Background: To investigate the role of soluble urokinase plasminogen activator receptor (Supar) in the diagnosis of diabetic foot infection and to determine whether it is superior to other markers of infection such as leukocytes, neutrophils, erythrocyte sedimentation rate, c-reactive protein and procalcitonin.

Methods: This prospective study comprised of four groups: group 1, healthy volunteers (n = 38); Group 2 patients without diabetic foot ulcers (n = 40); Group 3, diabetic patients with foot ulcers that are not infected (n = 33); and Group 4, patients with diabetic foot infections (n ​​= 48). In each group, leukocytes, neutrophils, erythrocyte sedimentation rate, c-reactive protein and procalcitonin and Supar level checked. The results were then statistically compared. Additionally, patients in Group 4 are further divided according to their infection is mild, moderate, and severe. Also osteomyelitis evaluated in Group 4 and statistics compared.

Results: All markers of infection was significantly higher in the group of 4 patients than those in the other three groups (p <0.05). Similarly, all markers of infection in the group of severe diabetic foot infection were statistically higher than the group of mild diabetic foot infection (p <0.05); However, only Supar and the erythrocyte sedimentation rate was significantly higher in cases with osteomyelitis (p <0.05).

In a receiver operating characteristic analysis, the optimal cut-off value for Supar determined to be 2.8 ng / ml, and the sensitivity and specificity above this value was 95.8% and 82.8%, respectively.

Conclusions: This study shows that Supar power is used as a support diagnostic methods for the diagnosis of diabetic foot infection.

The role of soluble urokinase plasminogen activator receptor (suPAR) in the diagnostics of diabetic foot infection.
The role of soluble urokinase plasminogen activator receptor (suPAR) in the diagnostics of diabetic foot infection.

Expression of Urokinase Plasminogen Activator reverse Established Lung Fibrosis.

Disorders plasminogen activation (PA) is causally related to the development of lung fibrosis. previous studies have shown that PA is enhanced in limiting the severity of lung scarring following injury and in vitro studies suggest that PA promotes matrix degradation and fibroblast apoptosis. These findings led us to hypothesize that the increased PA in vivo models will improve the resolution of pulmonary fibrosis was established in conjunction with an increase in myofibroblast apoptosis.

Transgenic C57BL / 6 mice with lung-specific induced urokinase plasminogen activator (uPA) expression doxycycline or treated littermate controls (day 0) with bleomycin or saline. Doxycycline started on day 1, 9, 14, or 21. Lung fibrosis, stiffness, apoptosis, epithelial barrier integrity, and inflammation was assessed. Protection of fibrosis with uPA upregulation of day 1 to day 28 was associated with reduced parenchymal stiffness as determined by atomic force microscopy.

Initiation of uPA expression begins at the end of inflammation or fibrosis initial phase of reduced stiffness and fibrosis on day 28. Induction of uPA activity in mice with established fibrosis lung collagen reduction and stiffness while increasing lung myofibroblast apoptosis. Upregulation of uPA not alter lung inflammation but are associated with increased epithelial cell homeostasis. Returns intrapulmonary PA activity decreased lung fibrogenesis and improve the resolution of established fibrosis of the lungs. This resolution PA-mediated myofibroblast apoptosis is associated with increased and improved epithelial cell homeostasis.

Cytokeratin HMW(34BE12) Antibody

BNCR0446-250 250uL
EUR 459.6
Description: Primary antibody against Cytokeratin, HMW(34BE12), RPE conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNUB0446-100 100uL
EUR 250.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), Concentration: 0.2mg/mL

Cytokeratin HMW(34BE12) Antibody

BNUB0446-500 500uL
EUR 549.6
Description: Primary antibody against Cytokeratin, HMW(34BE12), Concentration: 0.2mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC430446-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF543 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC430446-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF543 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC470446-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF647 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC470446-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF647 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC400446-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF640R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC400446-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF640R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC880446-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF488A conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC880446-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF488A conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC810446-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF680R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC810446-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF680R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNCP0446-250 250uL
EUR 459.6
Description: Primary antibody against Cytokeratin, HMW(34BE12), PerCP conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNUM0446-50 50uL
EUR 474
Description: Primary antibody against Cytokeratin, HMW(34BE12), 1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC050446-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF405M conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC050446-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF405M conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC700446-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF770 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC700446-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF770 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC800446-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF680 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC800446-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF680 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNCB0446-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), Biotin conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNCB0446-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), Biotin conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC940446-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF594 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC940446-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF594 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC550446-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF555 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC550446-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF555 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNCH0446-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNCH0446-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Kininogen, HMW, Human Plasma

7300-100
EUR 438

WSE-7210 EzFastBlot HMW

2332595 3unit
EUR 313.2
Description: H i gh-Speed for semi -dr y hi gh pol ymer (200k Da<) pr ot ei n

Human Kininogen (HMW) Antibody

20334-05011 150 ug
EUR 260.4

Cytokeratin HMW(34BE12) Antibody

BNC040446-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF405S conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC040446-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF405S conjugate, Concentration: 0.1mg/mL

Kininogen, HMW, Human Plasma

KINH15-N-50 50 ug
EUR 270

Anti-Cytokeratin, HMW antibody

STJ180151 0.1 ml
EUR 254.4

Anti-Cytokeratin, HMW antibody

STJ180152 0.1 ml
EUR 254.4

Caldesmon / CAD Antibody HMW

V2940-100UG 100 ug
EUR 499
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody HMW

V2940-20UG 20 ug
EUR 219
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody HMW

V2940IHC-7ML 7 ml
EUR 499
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody HMW

V2940SAF-100UG 100 ug
EUR 499
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody HMW

V2941-100UG 100 ug
EUR 499
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody HMW

V2941-20UG 20 ug
EUR 219
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody HMW

V2941IHC-7ML 7 ml
EUR 499
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody HMW

V2941SAF-100UG 100 ug
EUR 499
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody HMW

V2942-100UG 100 ug
EUR 499
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. This mAb recognizes only the 150kDa variant (h-caldesmon) in Western blots of human aortic media extracts and is unreactive with fibroblast extracts from cultivated human foreskin. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody HMW

V2942-20UG 20 ug
EUR 219
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. This mAb recognizes only the 150kDa variant (h-caldesmon) in Western blots of human aortic media extracts and is unreactive with fibroblast extracts from cultivated human foreskin. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody HMW

V2942IHC-7ML 7 ml
EUR 499
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. This mAb recognizes only the 150kDa variant (h-caldesmon) in Western blots of human aortic media extracts and is unreactive with fibroblast extracts from cultivated human foreskin. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody HMW

V2942SAF-100UG 100 ug
EUR 499
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. This mAb recognizes only the 150kDa variant (h-caldesmon) in Western blots of human aortic media extracts and is unreactive with fibroblast extracts from cultivated human foreskin. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody HMW

V3231-100UG 100 ug
EUR 499
Description: Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody HMW

V3231-20UG 20 ug
EUR 219
Description: Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody HMW

V3231SAF-100UG 100 ug
EUR 499
Description: Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody (HMW)

V7159-100UG 100 ug
EUR 499
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody (HMW)

V7159-20UG 20 ug
EUR 219
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody (HMW)

V7159IHC-7ML 7 ml
EUR 499
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody (HMW)

V7159SAF-100UG 100 ug
EUR 499
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody HMW

V7200-100UG 100 ug
EUR 499
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody HMW

V7200-20UG 20 ug
EUR 219
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody HMW

V7200IHC-7ML 7 ml
EUR 499
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody HMW

V7200SAF-100UG 100 ug
EUR 499
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody HMW

V7252-100UG 100 ug
EUR 499
Description: Caldesmon (CAD, CALD, CALD1) is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). [UniProt]

Caldesmon / CAD Antibody HMW

V7252-20UG 20 ug
EUR 219
Description: Caldesmon (CAD, CALD, CALD1) is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). [UniProt]

Caldesmon / CAD Antibody HMW

V7252IHC-7ML 7 ml
EUR 499
Description: Caldesmon (CAD, CALD, CALD1) is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). [UniProt]

Caldesmon / CAD Antibody HMW

V7252SAF-100UG 100 ug
EUR 499
Description: Caldesmon (CAD, CALD, CALD1) is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). [UniProt]

Cytokeratin HMW(AE-3) Antibody

BNCA0257-250 250uL
EUR 459.6
Description: Primary antibody against Cytokeratin, HMW(AE-3), APC conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNCA1076-250 250uL
EUR 459.6
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), APC conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNCAP0257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNCAP0257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNCAP1076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNCAP1076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC610257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF660R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC610257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF660R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC611076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF660R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC611076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF660R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC680257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF568 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC680257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF568 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNUM1076-50 50uL
EUR 474
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), 1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNCR0257-250 250uL
EUR 459.6
Description: Primary antibody against Cytokeratin, HMW(AE-3), RPE conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNCR1076-250 250uL
EUR 459.6
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), RPE conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNUB0257-100 100uL
EUR 250.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), Concentration: 0.2mg/mL

Cytokeratin HMW(AE-3) Antibody

BNUB0257-500 500uL
EUR 549.6
Description: Primary antibody against Cytokeratin, HMW(AE-3), Concentration: 0.2mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNUB1076-100 100uL
EUR 250.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), Concentration: 0.2mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNUB1076-500 500uL
EUR 549.6
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), Concentration: 0.2mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC430257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF543 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC430257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF543 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC431076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF543 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC431076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF543 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC470257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF647 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC470257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF647 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC051076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF405M conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC051076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF405M conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC400257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF640R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC400257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF640R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC401076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF640R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC401076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF640R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC811076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF680R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC811076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF680R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC880257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF488A conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC880257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF488A conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC881076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF488A conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC881076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF488A conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC801076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF680 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC801076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF680 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC810257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF680R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC810257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF680R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNCH1076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNCH1076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNCP0257-250 250uL
EUR 459.6
Description: Primary antibody against Cytokeratin, HMW(AE-3), PerCP conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNCP1076-250 250uL
EUR 459.6
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), PerCP conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNUM0257-50 50uL
EUR 474
Description: Primary antibody against Cytokeratin, HMW(AE-3), 1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC041076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF405S conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC041076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF405S conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC050257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF405M conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC050257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF405M conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC681076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF568 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC681076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF568 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC700257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF770 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC700257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF770 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC701076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF770 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC701076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF770 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC800257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF680 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC800257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF680 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNCB0257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), Biotin conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNCB0257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), Biotin conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNCB1076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), Biotin conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNCB1076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), Biotin conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC940257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF594 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC940257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF594 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC941076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF594 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC941076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF594 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC550257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF555 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC550257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF555 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC551076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF555 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC551076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF555 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNCD0257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), Digoxigenin conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNCD0257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), Digoxigenin conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNCH0257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNCH0257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC471076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF647 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC471076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF647 conjugate, Concentration: 0.1mg/mL

Mouse HMW ADNP ELISA Kit

EMA0537 96Tests
EUR 625.2

Mouse CK-HMW ELISA Kit

EMC0772 96Tests
EUR 625.2

Monkey HMW ADNP ELISA Kit

EMKA0537 96Tests
EUR 625.2

Sheep HMW ADNP ELISA Kit

ESA0537 96Tests
EUR 625.2

Human HMW ADNP ELISA Kit

EHA0537 96Tests
EUR 625.2

Human CK-HMW ELISA Kit

EHC0772 96Tests
EUR 625.2

Rat HMW ADNP ELISA Kit

ERA0537 96Tests
EUR 625.2

Porcine HMW ADNP ELISA Kit

EPA0537 96Tests
EUR 625.2

Rat CK-HMW ELISA Kit

ERC0772 96Tests
EUR 625.2

Rabbit HMW ADNP ELISA Kit

ERTA0537 96Tests
EUR 625.2

Rabbit CK-HMW ELISA Kit

ERTC0772 96Tests
EUR 625.2

Porcine CK-HMW ELISA Kit

EPC0772 96Tests
EUR 625.2

Adiponectin glycosilated, HMW Rich Protein

20-abx262998
  • EUR 393.60
  • EUR 8210.40
  • EUR 276.00
  • 10 ug
  • 1 mg
  • 2 µg

Chlamydia trachomatis HMW Protein Antibody

abx411206-02mg 0.2 mg
EUR 678

Cytokeratin HMW(AE-3) Antibody

BNC040257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF405S conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC040257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF405S conjugate, Concentration: 0.1mg/mL

Goat HMW ADNP ELISA Kit

EGTA0537 96Tests
EUR 625.2

Goat CK-HMW ELISA Kit

EGTC0772 96Tests
EUR 625.2

Bovine HMW ADNP ELISA Kit

EBA0537 96Tests
EUR 625.2

Bovine CK-HMW ELISA Kit

EBC0772 96Tests
EUR 625.2

Canine HMW ADNP ELISA Kit

ECA0537 96Tests
EUR 625.2

Canine CK-HMW ELISA Kit

ECC0772 96Tests
EUR 625.2

Chicken HMW ADNP ELISA Kit

ECKA0537 96Tests
EUR 625.2

Anserini CK-HMW ELISA Kit

EAC0772 96Tests
EUR 625.2

Gel Filtration HMW Calibration Kit

28403842 EACH
EUR 603.06

Caldesmon / CAD Antibody Cocktail (HMW)

V2943-100UG 100 ug
EUR 499
Description: Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody Cocktail (HMW)

V2943-20UG 20 ug
EUR 219
Description: Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody Cocktail (HMW)

V2943IHC-7ML 7 ml
EUR 499
Description: Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody Cocktail (HMW)

V2943SAF-100UG 100 ug
EUR 499
Description: Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon Antibody / CALD1 / CAD (HMW)

V8878-100UG 100ug
EUR 499
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. This MAb recognizes only the 150kDa variant (h-caldesmon) in Western blots of human aortic media extracts and is unreactive with fibroblast extracts from cultivated human foreskin. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon Antibody / CALD1 / CAD (HMW)

V8878-20UG 20ug
EUR 219
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. This MAb recognizes only the 150kDa variant (h-caldesmon) in Western blots of human aortic media extracts and is unreactive with fibroblast extracts from cultivated human foreskin. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon Antibody / CALD1 / CAD (HMW)

V8878SAF-100UG 100ug
EUR 499
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. This MAb recognizes only the 150kDa variant (h-caldesmon) in Western blots of human aortic media extracts and is unreactive with fibroblast extracts from cultivated human foreskin. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon Antibody / CALD1 / CAD (HMW)

V9402-100UG 100ug
EUR 499
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. This MAb recognizes only the 150kDa variant (h-caldesmon) in Western blots of human aortic media extracts and is unreactive with fibroblast extracts from cultivated human foreskin. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon Antibody / CALD1 / CAD (HMW)

V9402-20UG 20ug
EUR 219
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. This MAb recognizes only the 150kDa variant (h-caldesmon) in Western blots of human aortic media extracts and is unreactive with fibroblast extracts from cultivated human foreskin. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon Antibody / CALD1 / CAD (HMW)

V9402SAF-100UG 100ug
EUR 499
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. This MAb recognizes only the 150kDa variant (h-caldesmon) in Western blots of human aortic media extracts and is unreactive with fibroblast extracts from cultivated human foreskin. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Human Kininogen (HMW) AssayMax ELISA Kit

EK1001-1 96 Well Plate
EUR 475.2

Human Kininogen (HMW) AssayMax ELISA Kit

EK2001-1 96 Well Plate
EUR 475.2

Human Kininogen (HMW) Antibody (Biotin Conjugate)

20334-05021 150 ug
EUR 331.2

Guinea Pig HMW ADNP ELISA Kit

EGA0537 96Tests
EUR 625.2

Guinea Pig CK-HMW ELISA Kit

EGC0772 96Tests
EUR 625.2

Anti-AMACR+P63+HMW CK antibody

STJ180008 0.1 ml
EUR 381.6

Anti-AMACR+P63+HMW CK antibody

STJ180270 0.1 ml
EUR 342

Basic Cytokeratin Antibody (HMW / Type II)

V8314-100UG 100 ug
EUR 499
Description: This antibody is specific to cytokeratin 13, 14, 15 and 16. This antibody stains squamous carcinomas and adeno-squamous carcinomas but does not stain adenocarcinoma. This antibody is useful in differential staining of squamous carcinomas from adenocarcinomas and to differentiate benign and malignant tumors of prostate glands.

Basic Cytokeratin Antibody (HMW / Type II)

V8314-20UG 20 ug
EUR 219
Description: This antibody is specific to cytokeratin 13, 14, 15 and 16. This antibody stains squamous carcinomas and adeno-squamous carcinomas but does not stain adenocarcinoma. This antibody is useful in differential staining of squamous carcinomas from adenocarcinomas and to differentiate benign and malignant tumors of prostate glands.

Basic Cytokeratin Antibody (HMW / Type II)

V8314SAF-100UG 100 ug
EUR 499
Description: This antibody is specific to cytokeratin 13, 14, 15 and 16. This antibody stains squamous carcinomas and adeno-squamous carcinomas but does not stain adenocarcinoma. This antibody is useful in differential staining of squamous carcinomas from adenocarcinomas and to differentiate benign and malignant tumors of prostate glands.

Basic Cytokeratin Antibody (HMW / Type II)

V2327-100UG 100 ug
EUR 499
Description: This antibody recognizes HMW Keratin 1, 5, 10 and 14. In normal epithelia, it stains stratified epithelia, myoepithelial cells and basal cells in the prostate gland and bronchi. The HMW Cytokeratin antibody shows no reactivity with hepatocytes, pancreatic acinar cells, proximal renal tubules, or endometrial glands; there is no reactivity with cells derived from simple epithelia. Mesenchymal tumors, lymphomas, melanomas, neural tumors, and neuroendocrine tumors are negative with this mAb. It stains myoepithelial cells and has been shown to be useful in distinguishing prostate adenocarcinoma from benign prostate. It has also been useful in separating benign from malignant intraductal breast proliferations.

Basic Cytokeratin Antibody (HMW / Type II)

V2327-20UG 20 ug
EUR 219
Description: This antibody recognizes HMW Keratin 1, 5, 10 and 14. In normal epithelia, it stains stratified epithelia, myoepithelial cells and basal cells in the prostate gland and bronchi. The HMW Cytokeratin antibody shows no reactivity with hepatocytes, pancreatic acinar cells, proximal renal tubules, or endometrial glands; there is no reactivity with cells derived from simple epithelia. Mesenchymal tumors, lymphomas, melanomas, neural tumors, and neuroendocrine tumors are negative with this mAb. It stains myoepithelial cells and has been shown to be useful in distinguishing prostate adenocarcinoma from benign prostate. It has also been useful in separating benign from malignant intraductal breast proliferations.

Basic Cytokeratin Antibody (HMW / Type II)

V2327IHC-7ML 7 ml
EUR 499
Description: This antibody recognizes HMW Keratin 1, 5, 10 and 14. In normal epithelia, it stains stratified epithelia, myoepithelial cells and basal cells in the prostate gland and bronchi. The HMW Cytokeratin antibody shows no reactivity with hepatocytes, pancreatic acinar cells, proximal renal tubules, or endometrial glands; there is no reactivity with cells derived from simple epithelia. Mesenchymal tumors, lymphomas, melanomas, neural tumors, and neuroendocrine tumors are negative with this mAb. It stains myoepithelial cells and has been shown to be useful in distinguishing prostate adenocarcinoma from benign prostate. It has also been useful in separating benign from malignant intraductal breast proliferations.

Basic Cytokeratin Antibody (HMW / Type II)

V2327SAF-100UG 100 ug
EUR 499
Description: This antibody recognizes HMW Keratin 1, 5, 10 and 14. In normal epithelia, it stains stratified epithelia, myoepithelial cells and basal cells in the prostate gland and bronchi. The HMW Cytokeratin antibody shows no reactivity with hepatocytes, pancreatic acinar cells, proximal renal tubules, or endometrial glands; there is no reactivity with cells derived from simple epithelia. Mesenchymal tumors, lymphomas, melanomas, neural tumors, and neuroendocrine tumors are negative with this mAb. It stains myoepithelial cells and has been shown to be useful in distinguishing prostate adenocarcinoma from benign prostate. It has also been useful in separating benign from malignant intraductal breast proliferations.

Basic Cytokeratin Antibody (HMW / Type II)

V2329-100UG 100 ug
EUR 499
Description: Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI <5.7) and basic (pI >6.0) subfamilies. This antibody recognizes basic (Type II or HMW) cytokeratins, which include 67kDa (CK1); 64kDa (CK3); 59kDa (CK4); 58kDa (CK5); 56kDa (CK6); 52kDa (CK8). Many studies have shown the usefulness of keratin markers in cancer research and tumor diagnosis. The basic family clone AE3 is commonly used in combination with clone AE1 as a pan cytokeratin antibody acidic + basic cocktail (Cat No V2330).

These studies support the potential capacity of the lungs to scar finish in murine models.A promising molecular target for aggressive cancer urokinase receptor (Upar). A fully human, recombinant antibodies that bind Upar to form a stable compound that blocks the interaction of uPA-Upar (2G10) and internalized mainly through endocytosis shown efficacy in mouse xenograft models, triple negative breast cancer that is very aggressive (TNBC).

January 2023
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Recent Posts

Categories

Tags